Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising outcomes. However, the price of this innovative drug and its availability have become key topics for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its expensive nature presents a significant challenge t